Kempner Capital Management’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Kempner Capital Management’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-189,600	Closed	–	–	70
2016 Q3	$0	Hold	189,600	–	–	﹤0.01%	72
2016 Q2	$2K	Hold	189,600	–	–	﹤0.01%	70
2016 Q1	$69K	Buy	189,600 +80,000	+73%	+$29.1K	0.04%	72
2015 Q4	$80K	Buy	+109,600	New	+$97.3K	0.05%	72
2015 Q2	–	Sell	-9,600	Closed	-$24K	–	78
2015 Q1	$24K	Hold	9,600	–	–	0.02%	77
2014 Q4	$44K	Hold	9,600	–	–	0.02%	75
2014 Q3	$67K	Hold	9,600	–	–	0.03%	70
2014 Q2	$142K	Buy	+9,600	New	+$167K	0.06%	62

Kempner Capital Management's RCPI Position: Q4 2016 in Review

Kempner Capital Management sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2016, closing a stake of 189,600 shares.

Kempner Capital Management first reported a position in RCPI in Q2 2014 and held it in 8 quarters. The position peaked at $142K in Q2 2014. 1 fund tracked by Wall St. Rank holds RCPI as of Q4 2016.

Kempner Capital Management reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Kempner Capital Management sold 189,600 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2016.
Kempner Capital Management first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 8 quarters.
Kempner Capital Management's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $142K in Q2 2014.
1 fund tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2016.

Based on Kempner Capital Management's 13F filing for Q4 2016, filed 6 Jan 2017.